Skin irritation / corrosion

Administrative data

Confidentiality
[Not publishable]
Justification
[Not publishable]
Use restricted to selected regulatory programmes
[Not publishable]
Endpoint
skin irritation: in vitro / ex vivo
Type of information
experimental study
Adequacy of study
other information
Robust study summary
[Not publishable]
Used for classification
[Not publishable]
Used for SDS
[Not publishable]
Study period: start date
[Empty]
End date
[Empty]
Remark

[Empty]

Reliability
1 (reliable without restriction)
Rationale for reliability incl. deficiencies
other: see 'Remark'

According to: OECD Guideline for the testing of Chemicals 439: In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method (Original Guideline adopted July 26, 2013), and as described in detail in the Protocol for: In Vitro EpiDermTM Skin Irritation Test (EPI-200-SIT) for use with MatTek Corporation’s Reconstructed Human Epidermal Model EpiDerm (EPI-200), Rev. 1/19/2010

Data waiving
[Empty]
Justification for data waiving
[Empty]
Justification for type of information
[Empty]

Attached justification

Cross-reference

Data source

Reference
Data access
[Not publishable]
Data protection claimed
[Not publishable]

Materials and methods

Test guideline

#1 - Test guideline

Qualifier
according to guideline
Guideline
OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method)
Version / remarks

[Empty]

Deviations
[Empty]
Principles of method if other than guideline
[Empty]
GLP compliance
yes (incl. QA statement)

Test material

Test material information
Additional test material information
[Empty]
Specific details on test material used for the study
[Empty]
Specific details on test material used for the study (confidential)
[Not publishable]

In vitro test system

Test system
[Empty]
Source species
[Empty]
Cell type
[Empty]
Cell source
[Empty]
Source strain
[Empty]
Details on animal used as source of test system
[Empty]
Justification for test system used

[Empty]

Vehicle
[Empty]
Details on test system
[Empty]
Control samples
[Empty]
Amount/concentration applied
[Empty]
Duration of treatment / exposure

[Empty]

Duration of post-treatment incubation (if applicable)

[Empty]

Number of replicates
[Empty]

Test animals

Species
[Empty]
Strain
[Empty]
Details on test animals or test system and environmental conditions
[Empty]

Test system

Type of coverage
[Empty]
Preparation of test site
[Empty]
Vehicle
[Empty]
Controls
[Empty]
Amount / concentration applied

Each approximately 25 mg of the neat test item were applied to three skin equivalents. Additionally the test item treated skin equivalents were wetted with 25 µL DPBS per tissue.

Duration of treatment / exposure

The skin equivalents were exposed to the neat test item for on hour.

Observation period

[Empty]

Number of animals
[Empty]
Details on study design

Each approximately 25 mg of the neat test item and 30 µL of the positive control (5% SDS in deionised water) or the negative control (DPBS) were applied to each three skin equivalents per dose group. Additionally the test item treated skin equivalents were wetted with 25 µL DPBS per tissue. The skin equivalenst were exposed to the neat test item and the controls for 1 hour. Subsequently the test item as well as the controls were rinsed off the skin equivalents and they were further incubated for about 41 hours. Afterwatrds the viability was determined using the MTT assay.

High dose level used
[Empty]
Justification for deviation from the high dose level
[Not publishable]

Model and software

Model name and version

[Empty]

Software name and version

[Empty]

Remarks
[Not publishable]

Any other information on materials and methods incl. tables

[Not publishable]

Results and discussion

In vitro

Results

Other effects / acceptance of results

Compared to the relative absorbance value of the negative control the mean relative absorbance value was not reduced (100.8%) after exposure of the test item to the skin tissues. The threshold for irritancy is = 50%. Therefore, the test item is not considered to possess an irritant potential.

In vivo

Results

Irritant / corrosive response data
[Empty]
Other effects
[Empty]

Additional information about applicability domain and reliability of (Q)SAR predictions

Fit with the applicability domain
[Empty]
Justification for the fit with the applicability domain

[Empty]

Fit with the space defined by the training set of the model
[Empty]
Mechanistic and metabolic considerations

[Empty]

Similar substances with experimental data

Performance of the model for similar substances

[Empty]

Conclusions on applicability domain and reliability
[Empty]
Uncertainty
[Empty]

Any other information on results incl. tables

Results after treatment with (-)-Shikimic acid and the controls

Dose Group

Treat-ment Interval

Absorbance 570 nm
Tissue 1*

Absorbance 570 nm
Tissue 2*

Absorbance 570 nm
Tissue 3*

Mean Absorbance of 3 Tissues

Rel. Absorbance [%] Tissue 1, 2 + 3**

Relative Standard Deviation

[%]

Mean Rel. Absorbance [% of Negative Control]***

Negative Control

60 min

1.666

1.624

1.606

1.632

102.1
99.5
98.4

1.9

100.0

Positive Control

60 min

0.063

0.065

0.062

0.063

3.8
4.0
3.8

2.7

3.9

Test Item

60 min

1.592

1.599

1.744

1.645

97.5
98.0
106.8

5.2

100.8

 

*      Mean of three replicate wells after blank correction
**
       relative absorbance per tissue [rounded values]:
***
     relative absorbance per treatment group [rounded values]:

 

Optical evaluation of the MTT-reducing capacity of the test item after 1 hour incubation with MTT-reagent did not show blue colour.

The mean relative absorbance value of the test item, corresponding to the cell viability, did not decrease (100.8%; threshold for irritancy:=50%), consequently the test item was non irritant to skin. 

Overall remarks, attachments

Overall remarks
[Not publishable]

Attachments

Applicant's summary and conclusion

Interpretation of results
not irritating
Conclusions

In conclusion, it can be stated that in this study and under the experimental conditions reported, (-)-Shikimic acid is not irritant to skin.

Executive summary

This in vitro study was performed to assess the irritation potential of (-)-Shikimic acid by means of the Human Skin Model Test.

Each three tissues of the human skin model EpiDermwere treated with the test item, the negative or the positive control for 60 minutes.

Each about 25 mg of the test item was applied to each tissue.

30 µL of either the negative control (DPBS) or the positive control (5% SLS) were applied to each tissue.

The test item and the positive and negative controls were washed off the skin tissues after 60 minutes treatment. After further incubation for about 41 hours the tissues were treated with the MTT solution for 3 hours following approximately 70 hours extraction of the colorant from the cells. The amount of extracted colorant was determined photometrically at 570 nm.

After treatment with the negative control the absorbance values were well within the required acceptability criterion of mean OD equal or greater than 0.8 and less or equal than 2.8 for the 60 minutes treatment interval thus showing the quality of the tissues.

Treatment with the positive control induced a decrease in the relative absorbance compared to the negative control to 3.9% thus ensuring the validity of the test system.

The rel. standard deviations between the % variabilities of the test item, the positive and negative controls were below 6% (threshold of the "OECD Guideline for the Testing of Chemicals 439: In vitro Skin Irritation: Reconstructed Human Epidermis Test Method”: 18%), thus ensuring the validity of the study.

Compared to the relative absorbance value of the negative controlthe mean relative absorbance value was not reduced (100.8%) after exposure of the test item to the skin tissues. The threshold for irritancy is = 50%. Therefore, the test item is not considered to possess an irritant potential.